Here, SFN inhibited the IL-6R/STAT3 pathway but not affected the viability in GC cells; in addition, combined with SFN, the attenuation of CSC-like properties facilitated CDDP to exert the therapeutic functions. Here, STAT3 is linked to gastric cancer.